These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration. David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204 [TBL] [Abstract][Full Text] [Related]
23. Structural Characterization Study of a Lipid Nanocapsule Formulation Intended for Drug Delivery Applications Using Small-Angle Scattering Techniques. Urimi D; Hellsing M; Mahmoudi N; Söderberg C; Widenbring R; Gedda L; Edwards K; Loftsson T; Schipper N Mol Pharm; 2022 Apr; 19(4):1068-1077. PubMed ID: 35226500 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of surface deformability of lipid nanocapsules by drop tensiometer technique, and its experimental assessment by dialysis and tangential flow filtration. Hirsjärvi S; Bastiat G; Saulnier P; Benoît JP Int J Pharm; 2012 Sep; 434(1-2):460-7. PubMed ID: 22698864 [TBL] [Abstract][Full Text] [Related]
25. Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. Nehme H; Saulnier P; Ramadan AA; Cassisa V; Guillet C; Eveillard M; Umerska A PLoS One; 2018; 13(1):e0189950. PubMed ID: 29298353 [TBL] [Abstract][Full Text] [Related]
26. OPA quantification of amino groups at the surface of lipidic nanocapsules (LNCs) for ligand coupling improvement. Perrier T; Fouchet F; Bastiat G; Saulnier P; Benoît JP Int J Pharm; 2011 Oct; 419(1-2):266-70. PubMed ID: 21839821 [TBL] [Abstract][Full Text] [Related]
27. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging. Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818 [TBL] [Abstract][Full Text] [Related]
28. Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide. Groo AC; Matougui N; Umerska A; Saulnier P Int J Nanomedicine; 2018; 13():7565-7574. PubMed ID: 30532539 [TBL] [Abstract][Full Text] [Related]
29. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules. Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878 [TBL] [Abstract][Full Text] [Related]
30. Structure and phase equilibria of the soybean lecithin/PEG 40 monostearate/water system. Montalvo G; Pons R; Zhang G; Díaz M; Valiente M Langmuir; 2013 Nov; 29(47):14369-79. PubMed ID: 24205925 [TBL] [Abstract][Full Text] [Related]
31. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect. Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892 [TBL] [Abstract][Full Text] [Related]
32. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats. Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405 [TBL] [Abstract][Full Text] [Related]
33. The gastrointestinal stability of lipid nanocapsules. Roger E; Lagarce F; Benoit JP Int J Pharm; 2009 Sep; 379(2):260-5. PubMed ID: 19524655 [TBL] [Abstract][Full Text] [Related]
34. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery: Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528 [TBL] [Abstract][Full Text] [Related]
35. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia. Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853 [TBL] [Abstract][Full Text] [Related]
36. Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules. Groo AC; Mircheva K; Bejaud J; Ailhas C; Panaiotov I; Saulnier P; Ivanova T; Lagarce F Pharm Res; 2014 Jul; 31(7):1753-65. PubMed ID: 24469905 [TBL] [Abstract][Full Text] [Related]
37. Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells. Maupas C; Moulari B; Béduneau A; Lamprecht A; Pellequer Y Int J Pharm; 2011 Jun; 411(1-2):136-41. PubMed ID: 21463666 [TBL] [Abstract][Full Text] [Related]
38. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. de Castro Leão M; Raffin Pohlmann A; de Cristo Soares Alves A; Helena Poliselli Farsky S; Klimuk Uchiyama M; Araki K; Sandri S; Stanisçuaski Guterres S; Alves Castro I Eur J Pharm Biopharm; 2021 Feb; 159():99-107. PubMed ID: 33358940 [TBL] [Abstract][Full Text] [Related]
39. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules. Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449 [TBL] [Abstract][Full Text] [Related]
40. Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application. Yadava SK; Basu SM; Chauhan M; Sharma K; Pradhan A; V R; Giri J Colloids Surf B Biointerfaces; 2020 Jun; 190():110927. PubMed ID: 32169777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]